ResearchPod Summary
While spinal cord injury (SCI) is known to cause local damage and distal brain dysfunction—including cognitive and emotional impairment—it remains unclear whether cell-based therapies can concurrently address both spinal cord and hippocampal pathology. This study investigated whether repeated, sequential intrathecal transplantation of human umbilical cord mesenchymal stem cells (hUC-MSCs) could facilitate this 'brain-spinal co-repair' in female mice.
Researchers established a spinal cord contusion model in female mice. Starting seven days post-injury, they performed weekly intrathecal injections of hUC-MSCs for four weeks. The study employed a multidimensional battery of behavioral tests to assess motor function (Basso Mouse Scale, CatWalk), anxiety and depression-like behaviors (Open Field, Forced Swimming, and Tail Suspension tests), and long-term memory (Novel Object Recognition). Histological and molecular analyses of both the spinal cord (axonal regeneration, glial scarring, inflammatory cytokines) and the hippocampal CA1 region (synaptic structure, microglial activation, and pruning) were conducted to determine the underlying mechanisms of recovery.
Treatment with hUC-MSCs significantly improved hindlimb locomotor function and mitigated SCI-associated anxiety, depression, and memory deficits. At the spinal cord level, the therapy increased anti-inflammatory markers (IL-10), reduced glial scar formation (GFAP/CSPGs), and supported axonal preservation. In the hippocampus, the therapy normalized region-specific synaptic remodeling and restored microglial homeostatic functions. Specifically, hUC-MSCs enhanced the phagocytic capacity of microglia and improved their synaptic pruning activity in the dorsal hippocampus, while also promoting dendritic complexity and BDNF expression in the ventral hippocampus. These results suggest that hUC-MSCs regulate brain-spinal crosstalk by mitigating inflammatory cascades and restoring synaptic homeostasis.
This research provides preclinical evidence for an integrated, systemic approach to SCI treatment. By demonstrating that subacute cell therapy can simultaneously target distal cognitive and emotional impairments alongside motor deficits, the study supports the 'brain-spinal co-repair' paradigm, which could inform more holistic clinical rehabilitation strategies.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.